oasis-1 oral semaglutide 50 mg obesity nejm 2023 oasis 1 trial ECO 2026 🥼🧪Slide Deck: Efficacy and safety

Research demonstrates that these medicines affect early disease development by addressing critical pathophysiological mechanisms

Both forms must be taken consistently to achieve desired results, which requires long-term treatment plans

Insights From Post-Marketing Studies An observational cohort study involving 50,000 pregnant women with type 2 diabetes found no significant increase in birth defects among those who took GLP-1 medications early in their pregnancies, specifically around the time they discovered they were pregnant

There is also an increased desire for smaller, nutrient-dense portions emerging, which, Des Jardins says, is being driven both by GLP-1 use and a more general interest in healthier eating in younger generations

But heres a look at just a few of the benefits peptide therapy may offer: Muscle Growth and Athletic Performance Certain peptides, such as CJC-1295 and Ipamorelin, can support muscle development, improve strength, and boost endurance

Experts say patients who are taking semaglutide or considering treatment should discuss the risks and benefits with their doctors, especially those who have other known optic nerve problems such as glaucoma or preexisting visual loss